Table 2.
Attrition by participant characteristics (n=38).
| Characteristic | All (n=38) | Completers (n=24) | Lost to follow-up (n=14) | P value | ||
| Sex, n (%) | .48 | |||||
|
|
Female | 27 (71) | 18 (67) | 9 (33) |
|
|
| Male | 11 (29) | 6 (55) | 5 (46) |
|
||
| Race, n (%) | .34 | |||||
|
|
White | 35 (92) | 21 (60) | 14 (40) |
|
|
| Asian | 2 (5) | 2 (100) | 0 (0) |
|
||
| Black | 1 (3) | 1 (100) | 0 (0) |
|
||
| Marital status, n (%) | .28 | |||||
|
|
Married | 21 (55) | 11 (52) | 10 (48) |
|
|
| Divorced or widowed | 11 (29) | 8 (73) | 3 (27) |
|
||
| Single | 6 (16) | 5 (83) | 1 (17) |
|
||
| Education, n (%) | .42 | |||||
|
|
≤High school | 9 (24) | 4 (44) | 5 (56) |
|
|
| Some college | 12 (32) | 9 (75) | 3 (25) |
|
||
| College grad | 17 (45) | 11 (65) | 6 (35) |
|
||
| Employment, n (%) | .20 | |||||
|
|
Employed | 14 (37) | 9 (64) | 5 (36) |
|
|
| Retired | 13 (34) | 6 (46) | 7 (54) |
|
||
| Unemployed or on leave | 11 (29) | 9 (82) | 2 (18) |
|
||
| Income, n (%) | .66 | |||||
|
|
<US $10k | 4 (11) | 4 (100) | 0 (0) |
|
|
| US $10k-$30k | 4 (11) | 2 (50) | 2 (50) |
|
||
| US $30k-$70k | 8 (21) | 4 (50) | 4 (50) |
|
||
| >US $70k | 20 (53) | 13 (65) | 7 (35) |
|
||
| Missing | 2 (5) | 1 (50) | 1 (50) |
|
||
| Baseline tablet use, n (%) | <.01 | |||||
|
|
Never or rarely or monthly | 14 (37) | 4 (29) | 10 (71) |
|
|
| Occasionally or more | 24 (63) | 20 (83) | 4 (17) |
|
||
| Baseline gameplay history, n (%) | .85 | |||||
|
|
Never or rarely or monthly | 6 (16) | 4 (67) | 2 (33) |
|
|
| Occasionally or more | 32 (84) | 20 (63) | 12 (38) |
|
||
| Smoking since diagnosis, n (%) | .97 | |||||
|
|
Maintained or increased | 8 (21) | 5 (63) | 3 (38) |
|
|
| Decreased | 30 (79) | 19 (63) | 11 (37) |
|
||
| Quit attempts of >24 hours in past year, n (%) | .33 | |||||
|
|
No | 9 (24) | 4 (44) | 5 (56) |
|
|
| Yes, once | 9 (24) | 7 (78) | 2 (22) |
|
||
| Yes, more than once | 20 (53) | 13 (65) | 7 (35) |
|
||
| Cancer site, n (%) | .62 | |||||
|
|
Lung | 12 (32) | 7 (58) | 5 (42) |
|
|
| Gastrointestinal | 9 (24) | 4 (44) | 5 (56) |
|
||
| Gynecologic | 6 (16) | 5 (83) | 1 (17) |
|
||
| Colorectal | 5 (13) | 4 (80) | 1 (20) |
|
||
| Urologic | 2 (5) | 1 (50) | 1 (50) |
|
||
| Other | 4 (11) | 3 (75) | 1 (25) |
|
||
| Clinical stage, n (%) | .46 | |||||
|
|
0 | 3 (8) | 1 (33) | 2 (66.7) |
|
|
| I | 14 (37) | 8 (57) | 6 (42.9) |
|
||
| II | 7 (18) | 5 (71) | 2 (28.6) |
|
||
| III | 6 (16) | 3 (50) | 3 (50.0) |
|
||
| IV | 4 (11) | 3 (75) | 1 (25.0) |
|
||
| Missing (or 88 or 99) | 4 (11) | 4 (100) | 0 (0) |
|
||
| Arm, n (%) | .80 | |||||
|
|
Standard Care | 18 (47) | 11 (61) | 7 (39) |
|
|
| Quit It | 20 (53) | 13 (65) | 7 (35) |
|
||
| Gameplay (n=20), n (%) | .02 | |||||
|
|
Any | 8 (21) | 8 (100) | 0 (0) |
|
|
| None | 30 (79) | 16 (53) | 14 (47) |
|
||
| Age (current; years), mean (SD) | 57.11 (9.6) | 54.79 (9.1) | 61.07 (9.5) | .05 | ||
| Baseline Fagerstrom scorea, mean (SD) | 3.68 (2.2) | 3.41 (2.1) | 4.17 (2.5) | .35 | ||
| Years smoking (n=40), mean (SD) | 36.7 (12.6) | 34.43 (14.1) | 40.50 (8.8) | .16 | ||
| Baseline cigarettes per day (n=41), mean (SD) | 12.34 (14.7) | 11.10 (7.1) | 14.46 (22.8) | .50 | ||
| Baseline intention to abstain for 30 days (n=40), mean (SD) | 2.73 (2.1) | 3.04 (2.3) | 2.15 (1.8) | .23 | ||
| Baseline coping strategies, mean (SD) | .57 | |||||
|
|
Number used (of 13) | 8.47 (3.8) | 8.75 (4.2) | 8.00 (3.2) | ||
| Baseline situational self-efficacy, mean (SD) | .76 | |||||
|
|
Mean (of 16 items), range 0-100 | 57.05 (22.6) | 56.20 (24.2) | 58.52 (20.2) | ||
a0-2: Very low; 3-4: Low; 5: Medium; 6-7: High; 8-10: Very high or heavy.